Adverum Biotechnologies Inc. buy Chardan Capital
Start price
19.07.24
/
50%
€1.38
Target price
19.07.25
€36.70
Performance (%)
-
End price
20.07.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Adverum Biotechnologies Inc. | - | - | - |
| iShares Core DAX® | 0,88 % | 5,63 % | 8,48 % |
| iShares Nasdaq 100 | 2,39 % | 1,57 % | 28,41 % |
| iShares Nikkei 225® | 4,27 % | 2,52 % | 50,98 % |
| iShares S&P 500 | 1,17 % | 2,55 % | 23,60 % |
Comments by Chardan_Capital for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target raised by analysts at Chardan Capital from $4.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
In the thread Trading Adverum Biotechnologies Inc.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Chardan_Capital for Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
13.08.25
13.08.25
€28.26
13.08.26
13.08.26
-
02:15
02:15
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
15.05.25
15.05.25
€29.48
15.05.26
15.05.26
-
16.05.26
16.05.26
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
17.04.25
17.04.25
€29.04
17.04.26
17.04.26
-
18.04.26
18.04.26
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.51
19.03.24
19.03.24
€3.68
19.03.25
19.03.25
-8.61%
20.03.25
20.03.25

